BabyFormula

The agency is investigating whether any formula manufacturers coordinated before bidding for state contracts. The agency is investigating whether any formula manufacturers coordinated before bidding for state contracts. FOLLOW US ON GOOGLE NEWS Read original article here Denial of responsibility! Techno Blender is an automatic aggregator of the all world’s media. In each content, the hyperlink to the primary source is specified. All trademarks belong to their rightful owners, all materials to their authors.…

Mother holding a newborn in a hospital bed.Svetikd | E+ | Getty ImagesIn 2020, in a nondescript office building in Durham, North Carolina, a team of scientists used cells to recreate sugar and protein found in breast milk.The seemingly niche development could years later change the way infant nutrition is understood and distributed in America. Biomilq, the company behind the breakthrough, had been working for nearly a decade to replicate the process of making human milk — but outside of the body. Its advancement was made…

WASHINGTON—The baby-formula industry remains as vulnerable to safety problems and supply disruptions as it did more than a year ago, when a recall led to nationwide shortages, a former Food and Drug Administration official says in testimony submitted for a congressional hearing Tuesday.  “The nation remains one outbreak, tornado, flood, or cyberattack away from finding itself in a similar place to that of February 17, 2022,” Frank Yiannas, the former…

WASHINGTON–A proposed reorganization of the U.S. Food and Drug Administration would help the agency anticipate and prevent some elements of the baby-formula recall and ensuing shortage that panicked parents of young children last year, the agency’s commissioner said in an interview. However, the highly consolidated market for infant formula could continue to pose problems if one of the handful of facilities making formula was to shutter again, Dr. Robert Califf…

The Securities and Exchange Commission and Federal Trade Commission are investigating Abbott Laboratories ABT 0.62% ’ baby-formula business, the company said. The SEC’s enforcement division sent a subpoena to Abbott in December requesting information about its powder infant-formula business and related public disclosures, the company said Friday in a securities filing. In addition, Abbott said it received a civil…

Imported baby formula will be subject to tariffs again in the new year, after the expiration of exemptions implemented amid a nationwide shortage. Congress waived tariffs, which can be as high as 17.5%, to help families struggling to find formula after supply-chain problems and the closure of a crucial factory crimped supplies. A White House spokesman said the tariff waivers doubled the number of manufacturers selling baby formula in the U.S. Congress made the tariff waivers temporary as…

Abbott Laboratories has made leadership changes at its major baby-formula manufacturing plant and in its quality organization, following a temporary shutdown of the Sturgis, Mich., plant earlier this year after contamination was found. The Abbott Park, Ill., company also plans to spend about $500 million to build a new baby-formula plant in the U.S., after analyzing the market and concluding more capacity is needed, Chief Executive…

U.S. stores are still struggling to stock baby formula despite monthslong efforts by manufacturers and the Biden administration to boost supplies.Availability of powdered formula products in U.S. stores earlier this month dropped to the lowest level so far this year, with about 30% of products out of stock for the week ended July 3, according to the market-research firm IRI. While availability improved slightly last week, out-of-stock levels remain higher than in recent months, and shortages remain acute in states…

Abbott Laboratories ABT -0.21% has reopened its biggest factory after a shutdown last month that dealt another blow to efforts to replenish the country’s short supply of baby formula. Abbott on July 1 reopened its plant in Sturgis, Mich., following a nearly three-week closure that stemmed from severe thunderstorms that blew through southwest Michigan, a spokesman confirmed on Sunday. The company has restarted production of its EleCare…

This copy is for your personal, non-commercial use only. Distribution and use of this material are governed by our Subscriber Agreement and by copyright law. For non-personal use or to order multiple copies, please contact Dow Jones Reprints at 1-800-843-0008 or visit www.djreprints.com. https://www.wsj.com/articles/fda-will-allow-overseas-formula-makers-to-keep-selling-in-u-s-past-shortages-11657130408 This copy is for your personal, non-commercial use only. Distribution and use of this material are governed by our…